ETIOPATHOGENESIS AND THE OPPORTUNITIES OF LASEROTHERAPY OF ERYTHEMATO-TELEANGIECTATIC ROSACEA SUBTYPE


Cite item

Full Text

Abstract

Rosacea is a chronic relapsing skin disorder of a multifactorial nature, which affects up to 5% of the population in Russia. Great social significance of rosacea is due to a marked decrease in the quality of life of the patient in the absence of continuous monitoring and supporting corrective therapy. A significant role in the pathogenesis of the disease belongs to vascular pathology and immune disorders. Currently, local laser therapy with a neodymium laser with a wavelength of 1064 nm seems to be the most optimal from the point of view of efficiency and tolerability, the absence of systemic side effects and also having no limitations on the skin type of the patient’s skin.

About the authors

Anastasia Aleksandrovna Sharshunova

Federal state budgetary institution of additional professional education «Central State Medical Academy», Presidential Administration of the President of Russian Federation

Email: crystalclouds@yandex.ru
Central State Medical Academy, Presidential Administration of the President of Russian Federation, Moscow 121359, Moscow, Russia

L. S Kruglova

Federal state budgetary institution of additional professional education «Central State Medical Academy», Presidential Administration of the President of Russian Federation

121359, Moscow, Russia

K. V Kotenko

Federal state budgetary institution of additional professional education «Central State Medical Academy», Presidential Administration of the President of Russian Federation

121359, Moscow, Russia

G. V Sofinskaya

Federal state budgetary institution of additional professional education «Central State Medical Academy», Presidential Administration of the President of Russian Federation

121359, Moscow, Russia

References

  1. Powell F.C. Rosacea. N. Engl. J. Med. 2005; 352: 793-803.
  2. Del Rosso J.Q., Gallo R.L., Tanghetti E., Gallo R, Webster G., Tanghetti E., Eichenfield L. An evaluation of potential correlation between pathophysiologic mechanisms, clinical mani-festations, and management of rosacea. Cutis. 2013; 91(Suppl 3): 1-8.
  3. Потекаев Н.Н. Розацеа. СПб.; 2000
  4. Gupta M.A., Gupta A.K., Chen S.J., Johnson A.M. Comorbidity of rosacea and depression: an analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey-Outpatient Department data collected by the U.S. National Center for Health Statistics from 1995 to 2002. Br. J. Dermatol. 2005; 153(6): 1176-81.
  5. Elewsky B.E., Draelos Z., Dréno B., Jansen T., Layton A., Picardo M. Rosacea - global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group. J. Eur. Acad. Dermatol. Venereol. 2011; 25(2):188-200.
  6. Адаскевич В.П. Акне и розацеа. СПб.; 2000
  7. Del Rosso J.Q., Gallo R.L., Tanghetti E. An evaluation of potential correlation between pathophysiologic mechanisms, clinical manifestations, and management of rosacea. J. Clin. Aesthet. Dermatol. 2012; 5(3): 16-25.
  8. Wilkin J., Dahl M., Detmar M., Drake L., Liang M.H., Odom R., Powell F. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J. Am. Acad. Dermatol. 2004; 50(6): 907-12.
  9. Steinhoff M., Schauber J., Leyden J.J. New insights into rosacea pathophysiology: a review of recent findings. J. Am. Acad. Dermatol. 2013; 69(6 Suppl 1): S15-26.
  10. Jarmuda S., O’Reilly N., Zaba R., Jakubowicz O., Szkaradkiewicz A., Kavanagh K. Potential role of Demodex mites and bacteria in the induction of rosacea. J. Med. Microbiol. 2012; 61(Pt 11): 1504-10.
  11. Boixeda de Miquel D., Vázquez Romero М., Vázquez Sequeiros Е., Foruny Olcina J.R. Effect of Helicobacter pylori eradication therapy in rosacea patients. Rev. Esp. Enferm. Dig. 2006. 98(7): 501-9.
  12. Garnis-Jones S. Psychological aspects of rosacea. J. Cutan. Med. Surg. 1998; 2(Suppl 4): 4-9.
  13. Buechner S.A. Rosacea: an update. Dermatology. 2005; 210(2): 100-8.
  14. Zouboulis C., Katsambas A., Kligman A. (Eds.) Pathogenesis and Treatment of Acne and Rosacea. Berlin; 2014.
  15. Wilkin J., Dahl M., Detmar M., Drake L. Feinstein A., Odom R., Powell F. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J. Am. Acad. Dermatol. 2002; 46(4): 584-7.
  16. Del Rosso J.Q., Thiboutot D., Gallo R. Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 5: A guide on the management of rosacea. Cutis. 2014; 93(3): 134-8.
  17. Tan J., Berg M. Rosacea: Current state of epidemiology. J. Am. Acad. Dermatol. 2013; 69(6, Suppl 1): S27-35.
  18. Crawford G.H., Pelle M.T., James W.D. Rosacea: I. Etiology, pathogenesis, and subtype classification. J. Am. Acad. Dermatol. 2004; 51(3): 327-41.
  19. Бауманн Л. Косметическая дерматология. Принципы и практика. М.; 2012: 253-61.
  20. Потекаев Н.Н., Круглова Л.С. Лазер в дерматологии и косметологии. М.; 2012: 51-63, 174-7.
  21. Шептий О.В., Круглова Л.С., Корчажкина Н.Б., Котенко К.В., Яменсков В.В. Механизмы действия различных лазеров и дифференцированные показания к их применению (обзор литературы). Вестник новых медицинских технологий. 2014; (1): 156.
  22. Кацамбас А.Д., Лотти Т.М. (ред.) Европейское руководство по лечению дерматологических заболеваний. М.; 2014.
  23. Круглова Л.С., Котенко К.В., Корчажкина Н.Б., Турбовская С.Н. Физиотерапия в дерматологии. М.; 2016.

Copyright (c) 2017 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies